Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

A review of the economic evaluation of interventions for cardiovascular diseases in Spain.

Catalá-López F, García-Altés A, Alvarez-Martín E, Gènova-Maleras R, Morant-Ginestar C, Fernández de Larrea-Baz N.

Farm Hosp. 2012 May-Jun;36(3):163-5. doi: 10.1016/j.farma.2011.03.005. Epub 2011 Oct 22. Review. English, Spanish. No abstract available.

PMID:
22024013
2.

Economic evaluation of interventions for malignant neoplasms in Spain: systematic review and comparative analysis.

Catalá-López F, García-Altés A, Álvarez-Martín E, Gènova-Maleras R, Morant-Ginestar C, Arana E.

Farm Hosp. 2012 May-Jun;36(3):141-7. doi: 10.1016/j.farma.2011.02.011. Epub 2011 Oct 24. Review. English, Spanish.

PMID:
22030159
3.

Outcome assessment in cardiovascular cost-benefit studies.

O'Brien B, Rushby J.

Am Heart J. 1990 Mar;119(3 Pt 2):740-7; discussion 747-8. Review.

PMID:
2106767
4.

Bayesian estimation of cost-effectiveness from censored data.

Heitjan DF, Kim CY, Li H.

Stat Med. 2004 Apr 30;23(8):1297-309.

PMID:
15083484
5.

Clinical and economical outcome of a cardiopulmonary and metabolic rehabilitation program.

Di Naso FC, Pereira JS, Monteiro MB.

Arq Bras Cardiol. 2007 Oct;89(4):274; author reply 274-5. English, Portuguese. No abstract available.

6.

Economic benefits of secondary and tertiary cardiac rehabilitation: a critical study.

Shephard RJ.

Ann Acad Med Singapore. 1992 Jan;21(1):57-62. Review.

PMID:
1590659
7.

Using covariates to reduce uncertainty in the economic evaluation of clinical trial data.

Vázquez-Polo FJ, Negrín Hernández MA, López-Valcárcel BG.

Health Econ. 2005 Jun;14(6):545-57.

PMID:
15497202
8.

Difficulties in analyzing costs and benefits in outpatient cardiac rehabilitation programs.

Hepner N, Hayes SM.

NLN Publ. 1987 Dec;(20-2191):421-31. No abstract available.

PMID:
3122171
9.

Principles from clinical trials relevant to clinical practice: Part II.

Califf RM, DeMets DL.

Circulation. 2002 Aug 27;106(9):1172-5. Review. No abstract available.

10.

Quality indicators in cardiovascular care: the case for cardiac rehabilitation.

Thomas RJ, Witt BJ, Lopez-Jimenez F, King ML, Squires RW.

J Cardiopulm Rehabil. 2005 Sep-Oct;25(5):249-56. Review. No abstract available.

PMID:
16217225
11.

Cardiac rehabilitation.

Dinnes J, Kleijnen J, Leitner M, Thompson D.

Qual Health Care. 1999 Mar;8(1):65-71. No abstract available.

12.

From 4S to IDEAL: the health economics of the statin trials.

Lindgren P, Jönsson B.

Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):138-43. Review.

PMID:
19378393
13.

Power and sample size calculations for stochastic cost-effectiveness analysis.

Briggs AH, Gray AM.

Med Decis Making. 1998 Apr-Jun;18(2 Suppl):S81-92.

PMID:
9566469
14.

Numbers needed to treat (lives!) and numbers needed to save (money).

Ribichini F, Taggart D, Vassanelli C.

EuroIntervention. 2013 Jun 22;9(2):175-7. doi: 10.4244/EIJV9I2A28. No abstract available.

15.

A Bayesian approach to stochastic cost-effectiveness analysis.

Briggs AH.

Health Econ. 1999 May;8(3):257-61.

PMID:
10348420
16.

[Cost-effectiveness analysis in the economic assessment].

Prieto L, Sacristán JA, Antoñanzas F, Rubio-Terrés C, Pinto JL, Rovira J; Grupo ECOMED.

Med Clin (Barc). 2004 Apr 10;122(13):505-10. Spanish. No abstract available.

PMID:
15104948
17.

[Admission criteria for cardiac rehabilitation].

Greco C, Bianchi M, Rasile C.

G Ital Cardiol (Rome). 2010 May;11(5 Suppl 3):121S-123S. Italian. No abstract available.

PMID:
20879497
18.
19.

Health research: measuring the social, health and economic benefits.

Frank C, Nason E.

CMAJ. 2009 Mar 3;180(5):528-34. doi: 10.1503/cmaj.090016. Epub 2009 Jan 22. No abstract available.

20.

[Analysis of cost-effectiveness of simvastatin versus atorvastatin in the secondary prevention of cardiovascular events within the Brazilian public healthcare system].

Araujo DV, Ribeiro de Souza CP, Bahia LR, Rey HC, Dos Santos Junior B, Tura BR, Berwanger O, Buehler AM, Silva MT.

Value Health. 2011 Jul-Aug;14(5 Suppl 1):S29-32. doi: 10.1016/j.jval.2011.05.024. Portuguese.

Supplemental Content

Support Center